Literature DB >> 18422752

Individual tumorigenesis pathways of sporadic colorectal adenocarcinomas are associated with the biological behavior of tumors.

Jin C Kim1, Young K Cho, Seon A Roh, Chang S Yu, Gyungyub Gong, Se J Jang, Seon Y Kim, Yong S Kim.   

Abstract

Clinicopathologic features of sporadic colorectal adenocarcinomas were compared using integrated data from 224 [corrected] patients subjected to curative resection. Individual steps in the tumorigenesis pathway, that is, adenomatosis polyposis coli (APC), Wnt-activated, base excision repair mutations, mismatch repair defects, RAF-mediated, transforming growth factor (TGF)-beta-suppressed, bone morphogenic protein (BMP)-suppressed, and p53 alterations, were examined in terms of genetic and epigenetic changes, as well as protein expression. Genetic and molecular alterations of right colon cancers were distinct from those of left colon and rectal cancers. Rectal cancers showed the attenuated phenotype of left colon cancers. Tumors most frequently displayed either TGF-beta- or BMP-suppressed alterations (81.2%), followed by RAF-mediated alterations (78.6%), and mismatch repair defects (38.4%), constituting a total of 24 integrated pathways. Tumors lacking APC mutations or carrying the RAF alteration (V600E) were frequently associated with lymphovascular invasion and lymph node metastasis (P < 0.05). Poorly differentiated or mucinous adenocarcinomas were generally associated with high level microsatellite instability, Axin2 suppression, TGF-beta1 or BMPR1A suppression, loss of heterozygosity of D18S46 or D18S474, and absence of base excision repair mutations (P < 0.0001-0.05). Early tumor recurrence was significantly correlated with lack of APC mutations (P = 0.036). Moreover, tumors that concurrently displayed APC/Wnt-activated, TGF-beta/BMP-suppressed, and p53 alterations were significantly predisposed to early recurrence (P = 0.026). Our data clearly indicate that particular steps or pathways of colorectal tumorigenesis are closely associated with characteristic clinicopathologic features that, in turn, determine biological behavior, such as tumor growth, invasion, and recurrence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422752     DOI: 10.1111/j.1349-7006.2008.00819.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  12 in total

1.  Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer.

Authors:  Sang Nam Yoon; Sung Tae Oh; Seok-Byung Lim; Tae Won Kim; Jong Hoon Kim; Chang Sik Yu; Jin Cheon Kim
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Mismatch repair protein expression in patients with stage II and III sporadic colorectal cancer.

Authors:  Lihua Zhao
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

3.  Longitudinal molecular characterization of endoscopic specimens from colorectal lesions.

Authors:  Petra Minarikova; Lucie Benesova; Tereza Halkova; Barbora Belsanova; Stepan Suchanek; Jiri Cyrany; Inna Tuckova; Jan Bures; Miroslav Zavoral; Marek Minarik
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

4.  Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis.

Authors:  Crystal Morales; Saleh Rachidi; Feng Hong; Shaoli Sun; Xinshou Ouyang; Caroline Wallace; Yongliang Zhang; Elizabeth Garret-Mayer; Jennifer Wu; Bei Liu; Zihai Li
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

5.  Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change.

Authors:  Seon Ae Roh; Eun Young Choi; Dong Hyung Cho; Se Jin Jang; Seon Young Kim; Yong Sung Kim; Jin Cheon Kim
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

6.  A comparison of colon and rectal somatic DNA alterations.

Authors:  Martha L Slattery; Karen Curtin; Roger K Wolff; Kenneth M Boucher; Carol Sweeney; Sandra Edwards; Bette J Caan; Wade Samowitz
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

7.  Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers.

Authors:  Jin-Cheon Kim; Seon-Young Kim; Seon-Ae Roh; Dong-Hyung Cho; Dae-Dong Kim; Jeong-Hyun Kim; Yong-Sung Kim
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

8.  KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy.

Authors:  Jochen Gaedcke; Marian Grade; Klaus Jung; Markus Schirmer; Peter Jo; Christoph Obermeyer; Hendrik A Wolff; Markus K Herrmann; Tim Beissbarth; Heinz Becker; Thomas Ried; Michael Ghadimi
Journal:  Radiother Oncol       Date:  2009-11-11       Impact factor: 6.280

Review 9.  Genomic landscape of colorectal carcinogenesis.

Authors:  Jin Cheon Kim; Walter F Bodmer
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-20       Impact factor: 4.553

10.  Adenoma formation following limited ablation of p120-catenin in the mouse intestine.

Authors:  Whitney G Smalley-Freed; Andrey Efimov; Sarah P Short; Peilin Jia; Zhongming Zhao; M Kay Washington; Sylvie Robine; Robert J Coffey; Albert B Reynolds
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.